Differential expression of progesterone receptor isoforms related to PGR +331g/a polymorphism in endometriosis: A case-control study
This study found that endometriosis patients with the GA genotype of the PGR +331G/A polymorphism exhibited significantly higher PR-B mRNA expression compared to those with the GG genotype.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This case-control study examined differential expression of progesterone receptor (PGR) isoforms in relation to the PGR +331G/A polymorphism in women with endometriosis, using a genetic and expression-focused comparison between affected and control participants. The key finding was that PGR isoform expression differed according to the PGR +331G/A genotype, linking a specific genetic variant to altered progesterone receptor isoform profiles in endometriosis tissue/cells assessed by the study. The paper’s main limitation is its case-control design, which cannot establish causality between the polymorphism, receptor isoform expression, and endometriosis development. This paper is centrally about endometriosis—specifically, how PGR isoform expression relates to the PGR +331G/A polymorphism in endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,910 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (32)
- 17β-Hydroxysteroid Dehydrogenase-2 Deficiency and Progesterone Resistance in Endometriosis via openalex
- Association between polymorphisms in the progesterone receptor gene and endometriosis via openalex
- Endometriosis and Infertility via openalex
- Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex
- Outcome of in vitro fertilization in endometriosis-associated infertility: a 5-year database cohort study. via openalex
- Progesterone receptor +331G/A polymorphism in endometriosis and deep-infiltrating endometriosis via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis1 via openalex
- Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis via openalex
- The emerging use of aromatase inhibitors for endometriosis treatment via openalex
- The use of biochemical markers in the diagnosis of pelvic endometriosis via openalex
- W2099493891 via openalex
- W2103006840 via openalex
- W2103915343 via openalex
- W2105953995 via openalex
- W2114969667 via openalex
- W2116490370 via openalex
- W2124532120 via openalex
- W2164696506 via openalex
- W2594460083 via openalex
- W2814315072 via openalex
- W4253353642 via openalex
- W1967963412 via openalex
- W1971003087 via openalex
- W1989007353 via openalex
- W2010311608 via openalex
- W2011025558 via openalex
- W2016921243 via openalex
- W2020259713 via openalex
- W2064213048 via openalex
- W2079190330 via openalex
- W2084663681 via openalex
Cited by (3)
- MOLECULAR-GENETIC MARKERS OF INDIVIDUAL SENSITIVITY TO HORMONAL THERAPY IN THE TREATMENT OF ADVANCED FORMS OF ENDOMETRIOSIS 2026
- O PAPEL DOS POLIMORFISMOS GENÉTICOS NA ETIOLOGIA DA ENDOMETRIOSE 2022
- Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system 2022
Source provenance
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:22:35.348889+00:00